Neurochemical mechanism of muscular pain: Insight from the study on delayed onset muscle soreness

Kazue Mizumura,Toru Taguchi
DOI: https://doi.org/10.1186/s12576-023-00896-y
2024-01-26
The Journal of Physiological Sciences
Abstract:We reviewed fundamental studies on muscular pain, encompassing the characteristics of primary afferent fibers and neurons, spinal and thalamic projections, several muscular pain models, and possible neurochemical mechanisms of muscle pain. Most parts of this review were based on data obtained from animal experiments, and some researches on humans were also introduced. We focused on delayed-onset muscle soreness (DOMS) induced by lengthening contractions (LC), suitable for studying myofascial pain syndromes. The muscular mechanical withdrawal threshold (MMWT) decreased 1–3 days after LC in rats. Changing the speed and range of stretching showed that muscle injury seldom occurred, except in extreme conditions, and that DOMS occurred in parameters without muscle damage. The B2 bradykinin receptor—nerve growth factor (NGF) route and COX-2—glial cell line-derived neurotrophic factor (GDNF) route were involved in the development of DOMS. The interactions between these routes occurred at two levels. A repeated-bout effect was observed in MMWT and NGF upregulation, and this study showed that adaptation possibly occurred before B2 bradykinin receptor activation. We have also briefly discussed the prevention and treatment of DOMS.
physiology
What problem does this paper attempt to address?
The problem this paper attempts to address is the neurochemical mechanisms of muscle pain, particularly the mechanisms of Delayed Onset Muscle Soreness (DOMS). Specifically, the authors review basic research on muscle pain, including the characteristics of primary afferent fibers and neurons, spinal cord and thalamic projections, several muscle pain models, and possible neurochemical mechanisms. The paper focuses particularly on DOMS induced by lengthening contractions (LC), a phenomenon suitable for studying myofascial pain syndrome. The main research content includes: 1. **Characteristics of DOMS**: DOMS typically appears 1-3 days after lengthening contractions, characterized by a decrease in muscle mechanical withdrawal threshold (MMWT). 2. **Conditions for the occurrence of DOMS**: By altering the speed and range of stretching, it was found that muscle damage rarely occurs unless under extreme conditions. DOMS can occur without muscle damage. 3. **Neurochemical mechanisms**: The B2 bradykinin receptor-nerve growth factor (NGF) pathway and the cyclooxygenase-2 (COX-2)-glial cell line-derived neurotrophic factor (GDNF) pathway are involved in the development of DOMS. The interaction between these pathways occurs at two levels. 4. **Adaptive response**: The repeated training effect, i.e., the adaptive response of MMWT and NGF upregulation, was observed, suggesting that adaptation may occur before B2 bradykinin receptor activation. 5. **Prevention and treatment**: The prevention and treatment methods of DOMS are briefly discussed. Overall, this paper aims to gain a deeper understanding of the neurochemical mechanisms of DOMS, providing new insights for the study of myofascial pain syndrome.